Discover the Evexia advantage Start ordering today
Take advantage of all the time and money-saving features that Evexia Diagnostics has to offer. Simply click the button below to get started.
Register Now87498
Overview:
This assay is intended to be used as an aid in the diagnosis of enteroviral infections.
Weak cross-reactivity was observed with some strains of rhinovirus that could be present in respiratory samples, and a false-positive result is possible if samples contain these viruses.
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. Test results should be interpreted in conjunction with clinical observations and other laboratory data and not used as the sole basis for diagnosis.
Collection Instructions:
Sterile container (CSF, stool), universal transport medium (NP/throat swab, rectal swab).
To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.
Swabs and stools are stable at room temperature, refrigerated, or frozen for seven days. CSF is stable at room temperature or refrigerated for seven days and frozen for 90 days.
Take advantage of all the time and money-saving features that Evexia Diagnostics has to offer. Simply click the button below to get started.
Register Now